LMH STRATEGIC SOLUTIONS

Lobbying for ARDELYX, INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Pharmacy

Prescription drug payment reform. Pharmaceutical supply chain.

Medicare/Medicaid

General Medicare and Medicaid Issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.